Transgender couples

Home
Chapter 8
Transgender couples

Chapter 8 – Fertility Problems

Topic

Fertility Problems: An introduction
Improving fertility
Infertility
Assisted reproductive technologies (ART)
Fertility in same sex couples
- Female same sex relationships
- Male same sex relationships
Surrogacy
Transgender couples
Psychosocial issues
Resources
References

See more. Sign up now!

Find the information you need

Transgender couples desiring fertility treatment should be referred for expert advice. Depending on their circumstances, they may be able to provide their own gametes or may require donor eggs or sperm.

... Buy now

Baird D, Collins J, Egozcue J, Evers LH, Gianaroli L, Leridon H, et al. Fertility and ageing. Human Reproduction Update 2005;11(3):261-76.

National Institute for Health and Care Excellence (NICE). Fertility problems: Assessment and Treatment. Clinical Guideline 156. [Internet]. 2013 [cited 15 September 2015]. Available from: https://www.nice.org.uk/guidance/cg156/resources/fertility-problems-assessment-and-treatment-pdf-35109634660549.

Department of Health and Social Care. Expert Group on Commissioning NHS Infertility Provision – Regulated Fertility Services: A Commissioning Aid. [Internet]. United Kingdom Government; 2009 [updated 2009 June 18].

Poppe K, Velkeniers B, Glinoert D. Thyroid disease and female reproduction Clinical Endocrinology 2007;66(3):309-21.

Vil aL, Velasco I, González S, Morales F, Sánchez E, Torrejón S, et al. Controversies in endocrinology: On the need for universal thyroid screening in pregnant women. European Journal of Endocrinology 2013;170(1):R17-30.

van den Boogaard E, Vissenberg R, Land JA, van Wely M, van der Post JA, Goddijn M, Bisschop PH. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Human Reproduction Update. 2011;17(5):605-19.

Pilsgaard F, Grynneru A, Lossl K, Bungum L, Pinborg A. The use of anti-Mullerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counselling. AOGS. 2018;97:1105-13.

Tal R, Seifer DB, Wantman E, Baker V, Tal O. Antimullerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013. Fertil Steril. 2018;109(2).

Ra Oh S, Yi Choe S, Jean Cho Y. Clinical application of serum anti-Mullerian hormone in women. Clin Exp Reprod Med. 2019;46(2):50-9.

10.

Tremellen K, Savulescu J. Ovarian reserve screening: a scientific and ethical analysis. Human Reproduction. 2014;29(12):2606-14.

11.

Brezina P, Haberl E, Wallach W. At home testing: optimizing management for the infertility physician. Fertil Steril 2011;95(6):1867-78.

12.

Devroey P, Fauser BC, Diedrich K, Evian Annual Reproduction (EVAR) Workshop Group Approaches to improve the diagnosis and management of infertility. Human Reproduction Update. 2009;15(4):391-408.

13.

Semen Analysis [internet]. Healthy Male – Andrology Australia: 2018. Available from: https://www.healthymale.org.au/files/resources/semen_analysis_fact_sheet_healthy_male_2019.pdf.

14.

Royal Australian College of General Practitioners (RACGP). Guidelines for preventive activities in general practice [internet]. 8^th Melbourne: RACGP; 2012.

15.

Fact Sheet 41 – Cystic Fibrosis [internet]. Centre for Genetics Education: NSW Health; 2016 [updated 2019 Dec]. Available from: https://www.genetics.edu.au/publications-and-resources/facts-sheets/fact-sheet-41-cystic-fibrosis/view.

16.

Congenital bilateral absence of the vas deferens [internet]. US National Library of Medicine; 2018 [updated 2018 October]. Available from: https://ghr.nlm.nih.gov/condition/congenital-bilateral-absence-of-the-vas-deferens.

17.

Wang R, Kim BV, Wely M, Johnson NP, Costello MF, Zhang H, et al. Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis. BMJ. 2017;356(j138).

18.

Fitzgerald O, Paul RC, Harris K, Chambers GM. National Perinatal Epidemiology & Statistics Unit: Assisted reproductive technology in Australia and New Zealand 2016. [Internet]. Sydney; 2018. Available from: https://npesu.unsw.edu.au/sites/default/files/npesu/surveillances/Assisted%20Reproductive%20Technology%20in%20Australia%20and%20New%20Zealand%202016.pdf.

19.

De Neubourg D, Daels C, Elseviers M, Mangelschots K, Vercruyssen M, Van Royen E. Cumulative live-birth delivery after IVF/ICSI since the progressive introduction of single-embryo transfer. Reprod BioMed Online. 2010;20(6):836-42.

20.

Practice Committee of the American Society for Reproductive Medicine, Practice Committee of the Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99(1):37-43.

21.

The Central Register [internet]. NSW Health: NSW Government; 2017 [updated 2017 Jan 13]. Available from: https://www.health.nsw.gov.au/art/Pages/the-central-register.aspx.

22.

Assisted Reproductive Technology Act 2007 (NSW) s 69.

23.

Victorian Assisted Reproductive Treatment Authority (VARTA). [Internet]. Available from: http://www.varta.org.au/.

24.

Surrogacy Act 2010 (NSW) s 102.

Prev Next

Reproductive and Sexual Health Handbook

Chapter 8 – Fertility Problems

CONTENTS

Find the information you need

Transgender couples